Literature DB >> 21029240

An animal model of cortical and callosal pathology in multiple sclerosis.

Mario Mangiardi1, Daniel K Crawford, Xiaoyu Xia, Sienmi Du, Rebecca Simon-Freeman, Rhonda R Voskuhl, Seema K Tiwari-Woodruff.   

Abstract

The pathological and radiological hallmarks of multiple sclerosis (MS) include multiple demyelinated lesions disseminated throughout the white matter of the central nervous system (CNS). More recently, the cerebral cortex has been shown to be affected in MS, but the elucidation of events causing cortical demyelination has been hampered by the lack of animal models reflecting such human cortical pathology. In this report, we have described the presence of cortical gray matter and callosal white matter demyelinating lesions in the chronic experimental autoimmune encephalomyelitis (EAE) mouse model of MS. Similar to the pathological lesions of MS patients, EAE lesions have been classified as type I-leukocortical, type II-intracortical and type III-subpial. All of these lesions had varying degrees of demyelination, inflammatory cells and reactive astrocytes. Similar to MS, cortical layers during EAE showed demyelination, microglia activation, synaptic protein alterations and apoptotic cells. In addition, the callosal white matter during EAE had many inflammatory demyelinating lesions and axon degeneration. Functional electrophysiological conduction analysis showed deficits in both myelinated and unmyelinated callosal axons during early and late EAE. The chronic EAE mouse model has features that mimic cortical and callosal pathology of MS, and can be potentially used to screen agents to prevent these features of disease.
© 2010 The Authors; Brain Pathology © 2010 International Society of Neuropathology.

Entities:  

Mesh:

Year:  2010        PMID: 21029240      PMCID: PMC5233755          DOI: 10.1111/j.1750-3639.2010.00444.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  73 in total

1.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

2.  Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis.

Authors:  Laurie Beth J Morales; Kyi Kyi Loo; Hong-Biao Liu; Cory Peterson; Seema Tiwari-Woodruff; Rhonda R Voskuhl
Journal:  J Neurosci       Date:  2006-06-21       Impact factor: 6.167

3.  Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development.

Authors:  Barbara S Mallon; H Elizabeth Shick; Grahame J Kidd; Wendy B Macklin
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 4.  The pathology of MS: new insights and potential clinical applications.

Authors:  Sean J Pittock; Claudia F Lucchinetti
Journal:  Neurologist       Date:  2007-03       Impact factor: 1.398

Review 5.  Cortical pathology in multiple sclerosis.

Authors:  Christine Stadelmann; Monika Albert; Christiane Wegner; Wolfgang Brück
Journal:  Curr Opin Neurol       Date:  2008-06       Impact factor: 5.710

6.  Functional recovery of callosal axons following demyelination: a critical window.

Authors:  D K Crawford; M Mangiardi; X Xia; H E López-Valdés; S K Tiwari-Woodruff
Journal:  Neuroscience       Date:  2009-10-02       Impact factor: 3.590

Review 7.  Neuropathology of multiple sclerosis-new concepts.

Authors:  Barbara Kornek; Hans Lassmann
Journal:  Brain Res Bull       Date:  2003-08-15       Impact factor: 4.077

8.  Cortical demyelination can be modeled in specific rat models of autoimmune encephalomyelitis and is major histocompatibility complex (MHC) haplotype-related.

Authors:  Maria K Storch; Jan Bauer; Christopher Linington; Tomas Olsson; Robert Weissert; Hans Lassmann
Journal:  J Neuropathol Exp Neurol       Date:  2006-12       Impact factor: 3.685

9.  Diffuse cortical atrophy in a marmoset model of multiple sclerosis.

Authors:  Ian M Pomeroy; Elaine K Jordan; Joseph A Frank; Paul M Matthews; Margaret M Esiri
Journal:  Neurosci Lett       Date:  2008-03-28       Impact factor: 3.046

10.  The relation between inflammation and neurodegeneration in multiple sclerosis brains.

Authors:  Josa M Frischer; Stephan Bramow; Assunta Dal-Bianco; Claudia F Lucchinetti; Helmut Rauschka; Manfred Schmidbauer; Henning Laursen; Per Soelberg Sorensen; Hans Lassmann
Journal:  Brain       Date:  2009-03-31       Impact factor: 13.501

View more
  37 in total

1.  Diffusion tensor imaging identifies aspects of therapeutic estrogen receptor β ligand-induced remyelination in a mouse model of multiple sclerosis.

Authors:  Kelley C Atkinson; Jeong Bin Lee; Jonathan P C Hasselmann; Sung Hoon Kim; Alyson Drew; Joselyn Soto; John A Katzenellenbogen; Neil G Harris; Andre Obenaus; Seema K Tiwari-Woodruff
Journal:  Neurobiol Dis       Date:  2019-06-18       Impact factor: 5.996

2.  Chronic demyelination-induced seizures.

Authors:  Andrew S Lapato; Jenny I Szu; Jonathan P C Hasselmann; Anna J Khalaj; Devin K Binder; Seema K Tiwari-Woodruff
Journal:  Neuroscience       Date:  2017-01-30       Impact factor: 3.590

3.  Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis.

Authors:  Noriko Itoh; Roy Kim; Mavis Peng; Emma DiFilippo; Hadley Johnsonbaugh; Allan MacKenzie-Graham; Rhonda R Voskuhl
Journal:  J Neuroimmunol       Date:  2016-10-03       Impact factor: 3.478

4.  Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling.

Authors:  Anna Dellarole; Paul Morton; Roberta Brambilla; Winston Walters; Spencer Summers; Danielle Bernardes; Mariagrazia Grilli; John R Bethea
Journal:  Brain Behav Immun       Date:  2014-06-02       Impact factor: 7.217

5.  Neuronopathy in the motor neocortex in a chronic model of multiple sclerosis.

Authors:  Travis Burns; Laird Miers; Jie Xu; Alan Man; Monica Moreno; David Pleasure; Peter Bannerman
Journal:  J Neuropathol Exp Neurol       Date:  2014-04       Impact factor: 3.685

6.  Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging.

Authors:  Allan MacKenzie-Graham; Gilda A Rinek; Andrea Avedisian; Stefan M Gold; Andrew J Frew; Cynthia Aguilar; David R Lin; Elizabeth Umeda; Rhonda R Voskuhl; Jeffry R Alger
Journal:  Neuroimage       Date:  2011-12-13       Impact factor: 6.556

7.  Functional Effects of Cuprizone-Induced Demyelination in the Presence of the mTOR-Inhibitor Rapamycin.

Authors:  Hana Yamate-Morgan; Kelli Lauderdale; Joshua Horeczko; Urja Merchant; Seema K Tiwari-Woodruff
Journal:  Neuroscience       Date:  2019-01-29       Impact factor: 3.590

8.  Attenuation of corpus callosum axon myelination and remyelination in the absence of circulating sex hormones.

Authors:  Rhusheet Patel; Spencer Moore; Daniel K Crawford; Gemmy Hannsun; Manda V Sasidhar; Kevin Tan; Donna Molaie; Seema K Tiwari-Woodruff
Journal:  Brain Pathol       Date:  2013-02-04       Impact factor: 6.508

9.  Bringing CLARITY to gray matter atrophy.

Authors:  Rory D Spence; Florian Kurth; Noriko Itoh; Chandler R L Mongerson; Shannon H Wailes; Mavis S Peng; Allan J MacKenzie-Graham
Journal:  Neuroimage       Date:  2014-07-16       Impact factor: 6.556

10.  Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.

Authors:  Shalini Kumar; Rhusheet Patel; Spencer Moore; Daniel K Crawford; Nirut Suwanna; Mario Mangiardi; Seema K Tiwari-Woodruff
Journal:  Neurobiol Dis       Date:  2013-04-17       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.